“…Seven of the 21 reviews described within-class comparisons of different prostaglandins (i.e., one prostaglandin analog versus another), 9,11,13,16,18,19,22 and the remaining 14 of 21 reviews described between-class comparisons or a combination of within-class and between-class comparisons. 3–8,10,12,14,15,17,20,21,23 Some systematic reviews in the sample of 21 were published in well-regarded journals, including leading ophthalmology journals published in the United States and the United Kingdom. One-third of the reviews (7/21) were funded by the pharmaceutical industry.…”